Endometrial Cancer Trial, Recruiting NCT07120529 Sponsor: Medical University of Silesia Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT07120529
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who had a specific type of major surgery to remove the cervix and surrounding tissue (called a radical hysterectomy, classified as type B or C) for early-stage cervical cancer
  • People whose cancer was at an early stage at the time of diagnosis (known as FIGO stages IB1 or IIA1, but not IB3)
  • Surgery must have taken place between November 2018 and August 2025
  • People whose surgery was performed without the use of a tool called a manipulator inside the uterus during the procedure
  • People whose surgery included a protective step to shield the top of the vagina during the operation
  • People who had a cone-shaped tissue removal procedure before the main surgery (this was optional, not required)
  • People who had a lymph node mapping procedure as a first step before the main surgery (this was also optional)

Who may not be able to join:

  • Women who had surgery for a more advanced stage of cervical cancer (stages beyond IIA1, or stage IB3)
  • People where cancer was found to have spread to the lymph nodes, confirmed through detailed laboratory testing
  • People who have significant difficulty with daily activities due to their health condition (confirm with trial site)
  • People who are not willing to take part in the study
  • People who are not willing to have CT scans or gynaecological check-up examinations as part of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +48 502027943

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical University of Silesia
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
1 September 2030

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

OS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov